BD Experiencing Blood Culture Bottle Decreased Availability

The FDA stated that patient assessment and follow-up patient care are anticipated to be impacted by a shortage in the availability of BD Bactec blood culture medium bottles.

The bottles are purchased by BD from a vendor. The business said in June that it was dealing with the plastic bottles’ decreased availability for a number of months. Customers were informed by BD that the limitations had been controlled “with a variety of measures,” although users might begin to notice disruptions in accessibility.

The FDA wrote to medical professionals about the delay in the bottles’ supply a month before BD issued its first warning. The organisation is encouraging users to utilise the vials for individuals who exhibit clinical indications and symptoms of a bloodstream infection first and to do blood culture samples “when medically necessary.”

“We will fill customer orders regularly and as supply is available,” the business stated. By September, BD intends to provide an update on supplies.